Presynaptic regulation of glutamate release in the ventral tegmental area during morphine withdrawal

Olivier J. Manzoni, John Williams

Research output: Contribution to journalArticle

119 Citations (Scopus)

Abstract

The regulation of glutamate (Glu) release from the excitatory input to dopamine cells in the ventral tegmental area (VTA) during acute withdrawal from morphine was studied in slices from animals treated for 6-7 d with morphine. EPSCs were inhibited by opioid agonists acting at μ-subtype receptors but not by selective δ- or κ-subtype agonists. The opioid inhibition was reduced by 65% with the potassium channel blocker 4- aminopyridine (4-AP; 100 μM) and a 12-lipoxygenase inhibitor, baicalein (5 μM), suggesting that opioids acted via a transduction pathway involving activation of a voltage-dependent potassium conductance by lipoxygenase metabolites as has been shown in the periaqueductal gray (Vaughan et al., 1997). During withdrawal, neither the potency nor the efficacy of D-Ala-Met- enkephalin-Gly-ol (DAMGO) were changed; however, the blockade of μ-opioid inhibition by both 4-AP and baicalein was reduced. In addition, the potency of baclofen to depress EPSCs by GABA-B receptors and the effects of the GABA- uptake inhibitor NO-711 (10 μM) were increased in withdrawn rats. Finally, group 2 (but not group 4 or 1) metabotropic glutamate receptor-mediated presynaptic inhibition was also enhanced in morphine-withdrawn rats. These results suggest that one of the consequences of withdrawal from chronic morphine is an enhanced presynaptic inhibition of the excitatory inputs to the dopamine cells of the VTA. Inhibition of glutamate release during acute withdrawal would add to the inhibition of dopamine cells that is mediated by an augmented release of GABA (Bonci and Williams, 1997).

Original languageEnglish (US)
Pages (from-to)6629-6636
Number of pages8
JournalJournal of Neuroscience
Volume19
Issue number15
StatePublished - Aug 1 1999

Fingerprint

Ventral Tegmental Area
Morphine
Opioid Analgesics
Glutamic Acid
Dopamine
GABA Uptake Inhibitors
Potassium Channel Blockers
GABA-B Receptors
Lipoxygenase Inhibitors
Methionine Enkephalin
4-Aminopyridine
Periaqueductal Gray
Baclofen
Lipoxygenase
gamma-Aminobutyric Acid
Potassium
baicalein

Keywords

  • GABA
  • Glutamate
  • Metabotropic receptors
  • Morphine withdrawal
  • Opioid
  • Ventral tegmental area

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Presynaptic regulation of glutamate release in the ventral tegmental area during morphine withdrawal. / Manzoni, Olivier J.; Williams, John.

In: Journal of Neuroscience, Vol. 19, No. 15, 01.08.1999, p. 6629-6636.

Research output: Contribution to journalArticle

@article{b5c7c7474a804faaa36410a2a1aa13b9,
title = "Presynaptic regulation of glutamate release in the ventral tegmental area during morphine withdrawal",
abstract = "The regulation of glutamate (Glu) release from the excitatory input to dopamine cells in the ventral tegmental area (VTA) during acute withdrawal from morphine was studied in slices from animals treated for 6-7 d with morphine. EPSCs were inhibited by opioid agonists acting at μ-subtype receptors but not by selective δ- or κ-subtype agonists. The opioid inhibition was reduced by 65{\%} with the potassium channel blocker 4- aminopyridine (4-AP; 100 μM) and a 12-lipoxygenase inhibitor, baicalein (5 μM), suggesting that opioids acted via a transduction pathway involving activation of a voltage-dependent potassium conductance by lipoxygenase metabolites as has been shown in the periaqueductal gray (Vaughan et al., 1997). During withdrawal, neither the potency nor the efficacy of D-Ala-Met- enkephalin-Gly-ol (DAMGO) were changed; however, the blockade of μ-opioid inhibition by both 4-AP and baicalein was reduced. In addition, the potency of baclofen to depress EPSCs by GABA-B receptors and the effects of the GABA- uptake inhibitor NO-711 (10 μM) were increased in withdrawn rats. Finally, group 2 (but not group 4 or 1) metabotropic glutamate receptor-mediated presynaptic inhibition was also enhanced in morphine-withdrawn rats. These results suggest that one of the consequences of withdrawal from chronic morphine is an enhanced presynaptic inhibition of the excitatory inputs to the dopamine cells of the VTA. Inhibition of glutamate release during acute withdrawal would add to the inhibition of dopamine cells that is mediated by an augmented release of GABA (Bonci and Williams, 1997).",
keywords = "GABA, Glutamate, Metabotropic receptors, Morphine withdrawal, Opioid, Ventral tegmental area",
author = "Manzoni, {Olivier J.} and John Williams",
year = "1999",
month = "8",
day = "1",
language = "English (US)",
volume = "19",
pages = "6629--6636",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "15",

}

TY - JOUR

T1 - Presynaptic regulation of glutamate release in the ventral tegmental area during morphine withdrawal

AU - Manzoni, Olivier J.

AU - Williams, John

PY - 1999/8/1

Y1 - 1999/8/1

N2 - The regulation of glutamate (Glu) release from the excitatory input to dopamine cells in the ventral tegmental area (VTA) during acute withdrawal from morphine was studied in slices from animals treated for 6-7 d with morphine. EPSCs were inhibited by opioid agonists acting at μ-subtype receptors but not by selective δ- or κ-subtype agonists. The opioid inhibition was reduced by 65% with the potassium channel blocker 4- aminopyridine (4-AP; 100 μM) and a 12-lipoxygenase inhibitor, baicalein (5 μM), suggesting that opioids acted via a transduction pathway involving activation of a voltage-dependent potassium conductance by lipoxygenase metabolites as has been shown in the periaqueductal gray (Vaughan et al., 1997). During withdrawal, neither the potency nor the efficacy of D-Ala-Met- enkephalin-Gly-ol (DAMGO) were changed; however, the blockade of μ-opioid inhibition by both 4-AP and baicalein was reduced. In addition, the potency of baclofen to depress EPSCs by GABA-B receptors and the effects of the GABA- uptake inhibitor NO-711 (10 μM) were increased in withdrawn rats. Finally, group 2 (but not group 4 or 1) metabotropic glutamate receptor-mediated presynaptic inhibition was also enhanced in morphine-withdrawn rats. These results suggest that one of the consequences of withdrawal from chronic morphine is an enhanced presynaptic inhibition of the excitatory inputs to the dopamine cells of the VTA. Inhibition of glutamate release during acute withdrawal would add to the inhibition of dopamine cells that is mediated by an augmented release of GABA (Bonci and Williams, 1997).

AB - The regulation of glutamate (Glu) release from the excitatory input to dopamine cells in the ventral tegmental area (VTA) during acute withdrawal from morphine was studied in slices from animals treated for 6-7 d with morphine. EPSCs were inhibited by opioid agonists acting at μ-subtype receptors but not by selective δ- or κ-subtype agonists. The opioid inhibition was reduced by 65% with the potassium channel blocker 4- aminopyridine (4-AP; 100 μM) and a 12-lipoxygenase inhibitor, baicalein (5 μM), suggesting that opioids acted via a transduction pathway involving activation of a voltage-dependent potassium conductance by lipoxygenase metabolites as has been shown in the periaqueductal gray (Vaughan et al., 1997). During withdrawal, neither the potency nor the efficacy of D-Ala-Met- enkephalin-Gly-ol (DAMGO) were changed; however, the blockade of μ-opioid inhibition by both 4-AP and baicalein was reduced. In addition, the potency of baclofen to depress EPSCs by GABA-B receptors and the effects of the GABA- uptake inhibitor NO-711 (10 μM) were increased in withdrawn rats. Finally, group 2 (but not group 4 or 1) metabotropic glutamate receptor-mediated presynaptic inhibition was also enhanced in morphine-withdrawn rats. These results suggest that one of the consequences of withdrawal from chronic morphine is an enhanced presynaptic inhibition of the excitatory inputs to the dopamine cells of the VTA. Inhibition of glutamate release during acute withdrawal would add to the inhibition of dopamine cells that is mediated by an augmented release of GABA (Bonci and Williams, 1997).

KW - GABA

KW - Glutamate

KW - Metabotropic receptors

KW - Morphine withdrawal

KW - Opioid

KW - Ventral tegmental area

UR - http://www.scopus.com/inward/record.url?scp=0033178413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033178413&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 6629

EP - 6636

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 15

ER -